CELGENE UK MANUFACTURING (II) LIMITED

• ⚠

  Material uncertainty over going concern

  The financial statements have been prepared on a basis other than going concern, which includes, where appropriate, writing down assets to their realisable values. No adjustments arose as a result of ceasing to apply the going concern basis. The directors have assessed the company's future prospects and have determined that the company is non-trading and does not intend to recommence trading activities. Its remaining investments/assets and liabilities will be transferred to fellow group undertakings. Accordingly, the company is expected to be liquidated by Q2 2026.

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  —

  Not reported

• Cash

  -88.7%

  £6,930,084 → £784,560

• Net assets

  +3.5%

  £104,397,882 → £108,090,523

• Employees

  —

  Not reported

• Operating profit

  +40.9%

  -£52,280 → -£30,905

• Profit before tax

  -8.4%

  £5,372,540 → £4,923,521

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

1. CELGENE UK MANUFACTURING (II) LIMITED 2004-10-28 → present
2. PENN T LIMITED 2001-12-03 → 2004-10-28
3. INHOCO 2388 LIMITED 2001-08-16 → 2001-12-03

Accounting basis

FRS 101

Reporting scope

Standalone (parent only)

Auditor

Deloitte LLP

Audit opinion

Unqualified (clean)

Going concern

Material uncertainty disclosed

“The financial statements have been prepared on a basis other than going concern, which includes, where appropriate, writing down assets to their realisable values. No adjustments arose as a result of ceasing to apply the going concern basis. The directors have assessed the company's future prospects and have determined that the company is non-trading and does not intend to recommence trading activities. Its remaining investments/assets and liabilities will be transferred to fellow group undertakings. Accordingly, the company is expected to be liquidated by Q2 2026.”

Group structure

1. CELGENE UK MANUFACTURING (II) LIMITED · parent
   1. Celgene UK Manufacturing (III) Limited 100% · United Kingdom · Holding Company

Significant events

• “The company is planning to cease operations, and is now a non-trading holding entity, having mostly intercompany balances and transactions. The directors plan to liquidate the company by the end of Q2 2026.”
• “Its remaining investments/assets and liabilities will be transferred to fellow group undertakings. Accordingly, the company is expected to be liquidated by Q2 2026.”
• “The company holds 100% of the ordinary share capital of Celgene UK Manufacturing (III) Limited, a company incorporated in the United Kingdom, which entered into voluntary liquidation as of 2 May 2025 and is still in progress.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

4

last 12 months

Capital events

0

last 24 months

Officers appointed

0

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.